Home » Topics » BioWorld Science

BioWorld Science
RSS

Phase II/III trial studies SHR-1701 with BP-102 and XELOX in first-line metastatic colorectal cancer

July 19, 2021

Discovery of novel selective Axl inhibitor with antitumor activity in vivo

July 19, 2021

Clarity recruits patients with prostate cancer to evaluate PET imaging with [64Cu]SAR-bisPSMA

July 19, 2021

New neonatal murine model of Listeria monocytogenes meningitis developed

July 19, 2021

Scioto opens phase I study of SB-121 in participants with autistic disorder

July 19, 2021

BIX-119 leads to improved clinical benefit through blocking both IL-17 and IL-22

July 19, 2021

ABBV-CLS-7262 studied in phase I for ALS

July 19, 2021

Phase I trial investigates SHJ-002 for myopia in pediatric subjects

July 19, 2021

FDA clears IND for phase I trial of SYSA-1801 in advanced pancreatic cancer

July 19, 2021

UCB discloses new FCER1A mutant inhibitors

July 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...